---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-008006"
form_type: "8-K"
ticker: "NUWE"
cik: "0001506492"
company_name: "Nuwellis, Inc."
filed_at: "2025-03-11T23:59:59+00:00"
generated_at: "2026-05-24T23:36:12.536454+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Nuwellis Q4 revenue $2.3M (-9% YoY); net loss narrows to $1.5M from $7.9M

## Summary
- Q4 revenue $2.3M, down 9% YoY; consumables utilization +21%, critical care revenue +35%.
- Gross margin 58.4% vs 54.4% YoY; includes $150K voluntary recall expense.
- Operating loss $2.4M, improved from $3.6M; full-year cost reduction $5.9M (-26%).
- Net loss attributable to common $1.5M ($0.44/share) vs $7.9M ($54.48/share) YoY.
- Cash $5.1M, no debt; CMS payment for Aquadex increased 4x to $1,639 effective Jan 2025.

## SEC filing metadata
- accession: 0001140361-25-008006
- form_type: 8-K
- ticker: NUWE
- cik: 0001506492
- company_name: Nuwellis, Inc.
- filed_at: 2025-03-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506492/000114036125008006/0001140361-25-008006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506492/000114036125008006/ef20045179_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-008006
- JSON: https://secwatch.observer/filing/0001140361-25-008006.json
- Plain text: https://secwatch.observer/filing/0001140361-25-008006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.